#1 Clinical Trials Search in Europe

Mianserin Hydrochloride

Mianserin Hydrochloride, a medication used in the treatment of depression and sleep disorders, has been the subject of several clinical trials. These studies aim to investigate its effectiveness when combined with other antidepressants, its impact on sleep quality, and its potential benefits for patients with various mental health conditions. The trials explore different aspects of Mianserin’s use, including its effects on cognitive function, sleep disturbances in trauma-affected refugees, and its safety profile in elderly patients.

Table of Contents

What is Mianserin?

Mianserin hydrochloride, commonly referred to as mianserin, is a medication primarily used to treat depression and sleep problems associated with depression. It belongs to a class of drugs called tetracyclic antidepressants, which work differently from more common antidepressants like SSRIs (Selective Serotonin Reuptake Inhibitors)[1]. Mianserin is also classified as a NaSSA (Noradrenergic and Specific Serotonergic Antidepressant), which means it affects certain chemicals in the brain related to mood and sleep[1].

Conditions Treated with Mianserin

Mianserin is primarily used to treat:

  • Depression: Particularly in cases where sleep disturbances are a significant symptom[1].
  • Sleep problems associated with depression: Mianserin has been shown to have a positive effect on sleep issues that often accompany depression[1].
  • Post-Traumatic Stress Disorder (PTSD): Some studies have explored the use of mianserin in treating sleep disturbances in trauma-affected refugees with PTSD[2].

How Mianserin Works

Mianserin works by affecting certain neurotransmitters (chemical messengers) in the brain:

  • It influences the levels of serotonin (5-HT) and norepinephrine (NE), which are involved in mood regulation and sleep[1].
  • Unlike some other antidepressants, mianserin has a specific effect on sleep problems, which can be a significant issue for many people with depression[1].
  • Its mechanism of action is different from benzodiazepines like lorazepam, which are sometimes used for sleep problems but work by enhancing the effects of a neurotransmitter called GABA[1].

Usage and Dosage

Based on the clinical trials information:

  • Mianserin is typically taken orally, once a night before bedtime[1].
  • The effective dose can vary, but in one study, doses ranged from 10 to 30 mg per day[2].
  • It’s often used in combination with other antidepressants, particularly SSRIs like escitalopram[1].

Always follow your doctor’s instructions regarding dosage and timing of medication.

Clinical Studies and Effectiveness

Several clinical studies have investigated the effectiveness of mianserin:

  • A study (NCT05599126) is comparing the combination of mianserin and escitalopram to lorazepam and escitalopram in treating depression with sleep problems. The primary outcome is a 30% reduction in the Pittsburgh Sleep Quality Index (PSQI), which measures sleep quality[1].
  • Another study (NCT02761161) is examining the effects of mianserin in trauma-affected refugees with PTSD, comparing it to other treatments including Imagery Rehearsal Therapy (IRT). This study is measuring changes in sleep quality, nightmares, PTSD symptoms, depression, anxiety, and overall quality of life[2].

These studies aim to provide more information about mianserin’s effectiveness in treating depression, sleep problems, and potentially PTSD-related sleep disturbances.

Potential Side Effects

While specific side effects weren’t detailed in the provided clinical trial information, it’s important to note that all medications can have side effects. Common side effects of antidepressants may include:

  • Drowsiness or sedation (which can be beneficial for sleep problems)
  • Dry mouth
  • Dizziness
  • Weight gain
  • Constipation

Always discuss potential side effects with your healthcare provider and report any unusual symptoms you experience while taking mianserin.

Important Considerations

When considering or using mianserin, keep in mind:

  • Mianserin is often used as an add-on treatment to other antidepressants, particularly in cases where sleep problems are a significant issue[1].
  • It may be particularly useful for older adults (gerontopsychiatric patients) who are more susceptible to side effects from other medications[3].
  • The effectiveness and safety of mianserin may vary depending on individual factors, including age, other medications being taken, and overall health status.
  • Regular follow-ups with your healthcare provider are important to monitor the medication’s effectiveness and any potential side effects.

Remember, this information is based on clinical trial data and should not replace professional medical advice. Always consult with your healthcare provider for personalized information and guidance regarding your treatment.

Aspect Details
Primary Uses in Trials Treatment of depression with sleep problems, sleep disturbances in PTSD patients
Combination Therapies Combined with SSRIs (e.g., Escitalopram), compared with Lorazepam
Target Populations Patients with depression and sleep issues, trauma-affected refugees with PTSD, elderly patients
Administration Oral, typically taken once nightly before bedtime
Dosage Varies by study, up to 30 mg per day in some trials
Key Outcome Measures Sleep quality, depression symptoms, anxiety levels, cognitive function, overall quality of life
Safety Considerations Monitored for adverse effects, especially in elderly patients

FAQ

  • What is Mianserin Hydrochloride used for in clinical trials? Mianserin Hydrochloride is being studied in clinical trials for its potential benefits in treating depression, particularly in patients with sleep problems. It's also being investigated for its effects on sleep disturbances in trauma-affected refugees with PTSD.
  • How does Mianserin compare to other medications in these trials? In one study, Mianserin is being compared to Lorazepam when combined with Escitalopram for treating depression with sleep problems. Another trial compares Mianserin to standard treatment and Imagery Rehearsal Therapy for sleep disturbances in refugees with PTSD.
  • What are the potential benefits of Mianserin in these trials? Mianserin is being studied for its potential to improve sleep quality, reduce depression and anxiety symptoms, and possibly enhance cognitive function. In trauma-affected refugees, it's being investigated for its ability to alleviate sleep disturbances and PTSD symptoms.
  • How is Mianserin typically administered in these trials? In the trials mentioned, Mianserin is typically administered orally once a night before bedtime. The dosage varies, with one study mentioning a maximum dose of 30 mg per day as an add-on treatment to standard care.
  • What outcomes are being measured in these Mianserin trials? The trials are measuring various outcomes, including changes in sleep quality (using scales like the Pittsburgh Sleep Quality Index), reduction in depression and anxiety symptoms, improvements in cognitive function, and overall quality of life. Some studies also assess the safety and tolerability of Mianserin.

Ongoing Clinical Trials on Mianserin Hydrochloride

  • Study on the Effect of Ketamine and Esketamine in Patients with Major Depressive Disorder After First-Line Treatment Failure

    Recruiting

    3 1 1 1
    Investigated drugs:
    Austria Germany Greece Italy Spain

  • Testing a Pharmacogenetic-Guided Treatment Selection Strategy with Antidepressant Drug Combination for Patients with Depressive Disorder

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Spain

Glossary

  • Mianserin Hydrochloride: An antidepressant medication belonging to the NaSSA (Noradrenergic and Specific Serotonergic Antidepressant) class, used to treat depression and sleep disorders.
  • SSRI: Selective Serotonin Reuptake Inhibitor, a class of antidepressant medications that work by increasing levels of serotonin in the brain.
  • PTSD: Post-Traumatic Stress Disorder, a mental health condition triggered by experiencing or witnessing a terrifying event, often characterized by flashbacks, nightmares, and severe anxiety.
  • Cognitive Function: Mental abilities that involve thinking, learning, remembering, problem-solving, and decision-making.
  • Lorazepam: A benzodiazepine medication used to treat anxiety disorders and insomnia.
  • Escitalopram: An SSRI antidepressant used to treat depression and anxiety disorders.
  • Imagery Rehearsal Therapy (IRT): A cognitive-behavioral treatment for reducing chronic nightmares, particularly in individuals with PTSD.
  • Pittsburgh Sleep Quality Index (PSQI): A self-report questionnaire that assesses sleep quality and disturbances over a one-month period.
  • Pharmacovigilance: The science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems.
  • Gerontopsychiatric: Relating to the psychiatric care and treatment of elderly patients.

References

  1. https://clinicaltrials.gov/study/NCT05599126
  2. https://clinicaltrials.gov/study/NCT02761161
  3. https://clinicaltrials.gov/study/NCT02374567